Case Updates
First Circuit rejects challenges to criminal convictions under the Federal Food, Drug, and Cosmetic Act for commercially distributing an adulterated and misbranded medical device
December 14, 2023
U.S. Chamber files coalition amicus brief arguing that the First Amendment prohibits the government from criminalizing truthful, non-misleading speech about FDA-approved products, including speech about unapproved uses
July 28, 2021
Click here to view the amicus brief filed jointly by the U.S. Chamber of Commerce and Pharmaceutical Research and Manufacturers of America. Jeffrey L. Handwerker, Elisabeth S. Theodore, and Samuel F. Callahan of Arnold & Porter Kaye Scholer LLP and the U.S. Chamber’s Litigation Center served as co-counsel for the U.S. Chamber.